Weil Company Inc. Sells 10,080 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Weil Company Inc. lowered its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 29.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,708 shares of the financial services provider’s stock after selling 10,080 shares during the quarter. Houlihan Lokey accounts for about 1.5% of Weil Company Inc.’s portfolio, making the stock its 18th largest position. Weil Company Inc.’s holdings in Houlihan Lokey were worth $4,291,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HLI. Financial Life Planners purchased a new stake in Houlihan Lokey during the 4th quarter valued at $33,000. Golden State Wealth Management LLC bought a new position in Houlihan Lokey during the fourth quarter valued at $53,000. VisionPoint Advisory Group LLC purchased a new stake in shares of Houlihan Lokey in the fourth quarter valued at $62,000. First Horizon Advisors Inc. lifted its holdings in shares of Houlihan Lokey by 81.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 441 shares of the financial services provider’s stock worth $70,000 after acquiring an additional 198 shares during the last quarter. Finally, Quarry LP purchased a new position in shares of Houlihan Lokey during the 3rd quarter worth about $76,000. 78.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HLI. JMP Securities reissued a “market perform” rating on shares of Houlihan Lokey in a research note on Wednesday, January 29th. UBS Group increased their target price on Houlihan Lokey from $229.00 to $230.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. StockNews.com downgraded shares of Houlihan Lokey from a “buy” rating to a “hold” rating in a research note on Tuesday. JPMorgan Chase & Co. reduced their target price on shares of Houlihan Lokey from $172.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 29th. Finally, Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $192.00 price target (up previously from $170.00) on shares of Houlihan Lokey in a research note on Wednesday, January 29th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $194.40.

Houlihan Lokey Price Performance

Shares of Houlihan Lokey stock opened at $167.43 on Wednesday. The stock has a market cap of $11.74 billion, a price-to-earnings ratio of 31.95 and a beta of 0.69. The firm’s 50-day moving average is $177.09 and its two-hundred day moving average is $171.15. Houlihan Lokey, Inc. has a 1 year low of $121.81 and a 1 year high of $192.10.

Houlihan Lokey (NYSE:HLI) last issued its quarterly earnings data on Tuesday, January 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.13. Houlihan Lokey had a net margin of 16.00% and a return on equity of 20.04%. On average, equities analysts expect that Houlihan Lokey, Inc. will post 5.98 earnings per share for the current year.

Houlihan Lokey Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, March 15th. Stockholders of record on Monday, March 3rd will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, March 3rd. Houlihan Lokey’s payout ratio is 43.51%.

Houlihan Lokey Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.